Menu Search
Equities

Bionoid Pharma Inc

BINP:PKC

Bionoid Pharma Inc

Actions
  • Price (USD)0.20
  • Today's Change0.00 / 0.00%
  • Shares traded7.07k
  • 1 Year change-76.74%
  • Beta--
Data delayed at least 15 minutes, as of Sep 12 2024 20:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2011, cash reserves at Bionoid Pharma Inc fell by 983.41k. Cash Flow from Investing was negative at 9.53k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 808.55k for operations while cash used for financing totalled 158.40k.
Cash flow per share0.7537
Price/Cash flow per share7.98
Book value per share-0.1744
Tangible book value per share-0.2878
More ▼

Balance sheet in USDView more

Bionoid Pharma Inc uses little or no debt in its capital structure.
Current ratio0.0536
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.